BLTE Q2 2021 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena

BLTEBelite Bio, Inc

$7B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.25

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1,742

Free Cash Flow

-$1,779

Stock-Based Comp.

$604

Balance Sheet

Total Assets

$22M

Total Liabilities

$997,000

Stockholders' Equity

$21M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$2M	-$1M	-127.3%
Net Income	-$2M	-$1M	-123.5%